is tirzepatide fda approved for weight loss Grants a New Indication Obesity Management Mounjaro vs. Zepbound: The Same

Two years ago, Jennifer Kirtley looked down at the scale and saw 328 pounds

Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for goodPRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider

Encourage people living with obesity to engage with weight management programmes

On the cover, a new analysis of the SELECT trial confirms semaglutide lowers the risk of major heart problems in people who are overweight or obese and already have heart disease, even if they dont have diabetes

99%, third-party tested.